CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colon Cancer|Pancreatic Cancer|Sarcoma|Ovarian Cancer
Interventions: BIOLOGICAL: p53: 264-272 peptide|DRUG: CT-011
Sponsor: National Cancer Institute (NCI)